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The tobacco-related plant species Nicotiana benthamiana has recently emerged as a versatile expression
platform for the rapid generation of recombinant biopharmaceuticals, but product yield and quality
frequently suffer from unintended proteolysis. Previous studies have highlighted that recombinant
protein fragmentation in plants involves papain-like cysteine proteinases (PLCPs). For this reason, we
have now characterized two major N. benthamiana PLCPs in detail: aleurain-like protease (NbALP) and
cathepsin B (NbCathB). As typical for PLCPs, the precursor of NbCathB readily undergoes autocatalytic
activation when incubated at low pH. On the contrary, maturation of NbALP requires the presence of a
cathepsin L-like PLCP as processing enzyme. While the catalytic features of NbALP closely resemble those
of its mammalian homologue cathepsin H, NbCathB displays remarkable differences to human cathepsin
B. In particular, NbCathB appears to be a far less efﬁcient peptidyldipeptidase (removing C-terminal
dipeptides) than its human counterpart, suggesting that it functions primarily as an endopeptidase.
Importantly, NbCathB was far more efﬁcient than NbALP in processing the human anti-HIV-1 antibody
2F5 into fragments observed during its production in N. benthamiana. This suggests that targeted down-
regulation of NbCathB could improve the performance of this plant-based expression platform.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The tobacco-related plant species Nicotiana benthamiana is
currently receiving increasing attention as a promising host for the
rapid, versatile and safe production of biopharmaceuticals. For
instance, recent advances in expression technologies allow the
synthesis of monoclonal antibodies (mAbs) in N. benthamiana aturain-like protease; CathB,
ity-determining region; DTT,
lySc, glycinaldehyde semi-
Ab, monoclonal antibody;
thamiana; PLCP, papain-like
; PNGase F, peptide N-glyco-
netics and Cell Biology, Uni-
thgasse 18, A-1190 Vienna,
r B.V. This is an open access articleexceptionally high levels [1]. Furthermore, N. benthamiana lines
have been established which permit the production of mAbs with
customized N-glycan structures and thus superior biological ac-
tivities [2,3]. These unique features have been recently exploited for
the production of a highly potent mAb cocktail for the treatment of
infections with Ebola virus [4]. However, a signiﬁcant problem
frequently encountered during the production of therapeutic an-
tibodies in Nicotiana species is their proteolytic degradation within
the plants [5e9]. Recent studies have revealed that mAb frag-
mentation in N. benthamiana and Nicotiana tabacum involves the
action of serine and cysteine proteases [10,11]. Since papain-like
cysteine proteinases (PLCPs) are capable of generating mAb frag-
ments reminiscent of those observed in planta [10], it has been
suggested that these enzymes could contribute tomAb degradation
in tobacco-based expression platforms [12].
In recent years, substantial progress has been made in the
biochemical and structural characterization of PLCPs of both animal
and plant origin [13e15]. Three N. benthamiana PLCPs have beenunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(NbCathB) and NbCYP2 [16,17]. So far, only NbCathB has been
studied at the protein level to some extent [17]. Recent progress in
the development of activity-based probes for PLCPs has allowed the
detection of active species of these enzymes in different plants [18].
Using such probes, we could ﬁrmly establish the functional
expression of NbALP in N. benthamiana leaves [19].
To study the individual features of N. benthamiana PLCPs in
more depth, we have now used bacteria and insect cells to produce
recombinant forms of NbALP, NbCathB and NbCYP2. While re-
combinant NbCYP2 proved recalcitrant to puriﬁcation, the other
two proteases could be obtained in quantities allowing a detailed
characterization of their enzymatic properties using synthetic
substrates as well as an assessment of their capacity to degrade
monoclonal antibodies.
2. Materials and methods
2.1. Heterologous expression of N. benthamiana PLCPs in insect cells
The pro-NbALP sequence [16] was isolated from total leaf cDNA
by PCR using the forward primer 50-TTTCTAGAGGACCGG
CTACCTTCGC-30 and the reverse primer 50-AAGGTACCTCAGG-
CAACGACAGGGTAG-30. The PCR product was cleaved with XbaI and
KpnI (Fermentas, St. Leon-Rot, Germany) at the underlined sites and
ligated into pVTBacHis-FLAG [20] digested with the same enzymes.
In the resulting plasmid pVTBacHis-FLAG-NbALP, the pro-NbALP
sequence is positioned in-frame behind a leader segment consist-
ing of the melittin signal peptide followed by a 4-kDa linker region
containing six consecutive histidine residues and the FLAG epitope.
The plasmid pMDC84-NbCathB [17] and the oligonucleotides 50-
AAATCTAGAGAACAACCAATATCCCAAGCTAAAG-30 (sense) and 50-
TCTGGTACCTCACATTGCGGCGTCAAG-30 (antisense) were used to
amplify the pro-NbCathB sequence, concomitantly adding a stop
codon. The fragment thus obtained was then cloned into
pVTBacHis-FLAG as outlined above.
By comparison with the draft sequence of the N. benthamiana
genome [21], it became apparent that the published NbCYP2
sequence [16] was missing 10 amino acids at its C-terminus (Thr-
Ala-Ala-His-Thr-Thr-Asn-Pro-Asn-Leu). A cDNA fragment encoding
full-length pro-NbCYP2 was isolated from total leaf cDNA by PCR
using the primers 50-GACTCTAGATTCTCCGACGAGGATCCG-30 and
50-GCAGGTACCTCACAGGTTAGGATTAGTAGTATGG-30. The resulting
PCR product was then ligated into pVTBacHis-FLAG as above.
Heterologous production of NbALP, NbCathB and NbCYP2 in
insect cells was then conducted according to previously published
procedures [20,22]. Brieﬂy, recombinant baculoviruses were
generated by co-transfection of Spodoptera frugiperda Sf9 cells with
the respective pVTBacHis-FLAG construct and baculoviral DNA.
After infection of S. frugiperda Sf21 cells, the recombinant proteins
were isolated from the culture supernatants by metal-chelate and
anti-FLAG afﬁnity chromatography.
2.2. Production of NbCYP2 in Escherichia coli
The pro-NbCYP2 sequence was ampliﬁed with suitable primers
(50-GCAGCTAGCTTCTCCGACGAGGATCCGTTG-30 and 50-GCACTC-
GAGTCACAGGTTAGGATTAG-30). The PCR product was cleaved with
NheI and XhoI at the underlined positions and then ligated into the
corresponding sites of pET-32/28 prior to expression in the
Escherichia coli strain Rosetta-gami B (DE3) pLysS as described
previously for mammalian cysteine cathepsins [23]. The resulting
cell pellet was then resuspended in 20 mM Hepes (pH 7.4) sup-
plemented with 500mMNaCl and 20mM imidazole. After cell lysis
by sonication, debris was removed by centrifugation at 16,000 g for15 min at 4 C. The supernatant was then passed through a column
of Chelating Sepharose (GE Healthcare, Little Chalfont, United
Kingdom) charged with Ni2þ ions and equilibrated in the resus-
pension buffer. After successive washes with 40 mM, 60 mM and
80 mM imidazole, the recombinant protein was eluted with
250 mM imidazole. Protein-containing eluate fractions were
pooled, dialysed against 20 mM Tris/HCl (pH 7.4) containing
150 mM NaCl and 0.02% (w/v) NaN3, and then concentrated by
ultraﬁltration.
2.3. Activation of PLCP precursors
NbALP (0.4 mg/ml) was activated by treatment with recombi-
nant human cathepsin L (15 mg/ml; [24]) in 0.1 M sodium acetate
(pH 5.0), 2.5 mM dithiothreitol (DTT) for 30 min at 37 C. Cathepsin
L was then removed by repeated incubation (2  15 min, ambient
temperature) with Gly-Phe-GlySc-Sepharose beads, which bind the
enzyme very tightly [25]. Control experiments veriﬁed that NbALP
samples puriﬁed by this procedure did not contain detectable
amounts of residual cathepsin L. NbCathB (1.0 mg/ml) was acti-
vated by treatment with 20 mg/ml pepsin (SigmaeAldrich, St. Louis,
USA) in 0.1 M sodium acetate (pH 4.5), 2.5 mM DTT for 30 min at
37 C. The processing enzyme was then quantitatively inhibited by
addition of 10 mM pepstatin A (SigmaeAldrich). For determination
of its autoprocessing sites, NbCathB was incubated in 0.1 M sodium
acetate (pH 4.5) supplemented with 2.5 mM DTT and 20 mg/ml
dextran sulphate for 30 min at 37 C. Autocatalytic activation of
NbCYP2was achieved by incubation in 0.1M sodium formate buffer
(pH 3.0) for 10 min at 30 C.
2.4. PLCP activity assays
Stopped assays were performed at 30 C (NbCYP2) or 37 C
(NbALP, NbCathB) as outlined previously [26,27], using the
following 4-methylcoumaryl-7-amide (MCA) substrates (Bachem,
Bubendorf, Switzerland) and buffers: 100 mM Arg-MCA in 0.1 M
Mes (pH 6.8), 5 mM DTT (NbALP); 10 mM Z-Phe-Arg-MCA or Z-Arg-
Arg-MCA in 0.1 M sodium acetate (pH 4.5), 5 mM DTT (NbCathB);
10 mM Z-Phe-Arg-MCA in 0.1 M Mes (pH 6.0), 5 mM DTT (NbCYP2).
2.5. Determination of kinetic constants
The concentrations of activated NbALP and NbCathB were
determined by active-site titration with the irreversible PLCP in-
hibitor E64 [28]. Kinetic measurements were performed at 25 C
following previously published procedures [23,24]. Buffers and
substrates were the same as stated above. NbCathB and recombi-
nant human cathepsin B [23] were also analysed with Abz-Phe-
Arg-Phe(NO2)-Ala ([29]; John S. Mort, Shriners Hospital for Chil-
dren, Montreal, Canada) and Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH
([30]; Bachem). Hydrolysis of these internally quenched ﬂuores-
cence substrates was monitored ﬂuorimetrically at lex ¼ 320 nm
and lem ¼ 420 nm. Reaction rates were determined from the
respective progress curves. The kinetic parameters Km and kcat were
derived by non-linear regression analysis using the Henri-
Michaelis-Menten equation and GraphPad Prism 5.0 software.
2.6. PLCP proﬁling with activity-based probes
Active-site labelling of NbCYP2 was performed in 0.1 MMes (pH
6.0) supplemented with 2 mM cysteine and 100 mM DCG-04 ([31];
Matthew Bogyo, Stanford University, USA) for 30 min at 30 C.
NbALP and NbCathB were labelled with varying concentrations of
DCG-04, biotin-Leu-Val-Gly-CHN2 ([32]; Gilles Lalmanach, Univer-
sity of Tours, France) or biotin-CA074 ([33]; Norbert Schaschke,
Fig. 1. Characterization of NbCYP2. (a) Recombinant NbCYP2 produced in E. coli was
autoactivated and then labelled with 100 mM DCG-04 for 30 min at 30 C prior to
analysis by SDS-PAGE and western blotting using streptavidin-peroxidase for detec-
tion. (b) Extracts of insect cells expressing NbCYP2 were subjected to treatment with
PNGase F or Endo H prior to immunoblotting analysis with anti-FLAG antibodies. The
migration positions of prestained molecular mass standards are indicated, with their
respective masses expressed in kDa.
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containing 5 mM DTT for 30 min at 37 C. The reactions were then
stopped by addition of 50 mg/ml E64 and subsequent treatment
for 5 min at 95 C.
2.7. mAb digestion with N. benthamiana PLCPs
The human anti-HIV-1 mAbs 2F5 and 2G12 (Dietmar Katinger,
Polymun Scientiﬁc GmbH, Klosterneuburg, Austria) were tested for
their susceptibility to N. benthamiana PLCPs as outlined earlier [10].
Brieﬂy, 2F5 or 2G12 (200 mg/ml) were treated with the respective
protease (50 mg/ml) in 0.1 M sodium acetate (pH 5.5) containing
2 mM DTT at 37 C. After incubation for up to 16 h, reactions were
stopped by incubation for 5 min at 95 C.
2.8. SDS-PAGE and western blotting analysis
Samples were denatured for 5 min at 95 C under reducing
conditions and then subjected to 12.5% SDS-PAGE. Separated
polypeptides were then either subjected to silver staining or elec-
trophoretically transferred onto Hybond-C nitrocellulose mem-
branes (GE Healthcare). After probing the membranes with
monoclonal mouse anti-FLAG M2 (SigmaeAldrich) or anti-aleurain
1D2 antibodies ([34]; Thomas Okita and John Rogers, Washington
State University, Pullman, USA), bound immunoglobulins were
visualized with peroxidase-conjugated goat anti-mouse IgG anti-
bodies (Jackson ImmunoResearch, West Grove, USA) and enhanced
chemiluminescence reagents (Bio-Rad, Richmond, USA). mAbs and
their heavy-chain fragments were detected with peroxidase-
labelled anti-human IgG (g-chain-speciﬁc; SigmaeAldrich).
Streptavidin-peroxidase (Vector Laboratories, Burlingame, USA)
was used for the detection of biotinylated proteins on western
blots.
2.9. Other methods
N-terminal sequence analysis of blotted bands was performed at
the Department of Molecular and Biomedical Sciences (Jozef Stefan
Institute, Ljubljana, Slovenia) and the Protein Micro-Analysis Fa-
cility (Medical University of Innsbruck, Austria) as reported earlier
[10]. Enzymatic deglycosylation of proteins was performed as
previously described [22]. Total protein content was determined
with the BCA Protein Assay Kit (Pierce, Rockford, USA), using bovine
serum albumin as standard.
3. Results
3.1. Heterologous expression of NbCYP2
The isolation of a cDNA covering almost the entire open reading
frame of NbCYP2 has been previously described [16]. This sequence
(UniProt: Q2QFR2) lacks the 10 C-terminal amino acids, which
could be deduced by alignment with the N. benthamiana draft
genome [21]. Altogether, full-length NbCYP2 (365 amino acids;
40.3 kDa) consists of an N-terminal signal peptide (20 amino acids),
an autoinhibitory proregion (111 residues) featuring the ERFNAQ
motif characteristic for cathepsin F-like PLCPs [14,15], and the
catalytic domain (234 amino acids; 25.2 kDa) containing the three
active-site residues involved in substrate hydrolysis (Cys156, His298
and Asn325; preproprotein numbering). Furthermore, NbCYP2
contains a single potential N-glycosylation site (Asn249) located in
the mature part of the protein (Supplementary Table S1). Since
another cathepsin F-like PLCP, barley HvPap-1, has been success-
fully expressed in E. coli [35], we initially attempted to produce
NbCYP2 in the same host. However, only minute amounts ofcatalytically competent protein could be obtained, thus precluding
a detailed characterization of the enzyme. Nevertheless, incubation
of recombinant NbCYP2 at low pH triggered its maturation into a
28-kDa form which could be labelled with the activity-based PLCP
probe DCG-04 (Fig. 1a). Furthermore, we could demonstrate that
autoprocessed NbCYP2 is capable of hydrolysing the PLCP substrate
Z-Phe-Arg-MCA. As characteristic for PLCPs, this activity was
abolished by treatment with E64 (not shown).
It has been observed before that the baculovirus expression
system can be better suited for the production of plant PLCPs than
bacteria or yeasts [36]. We have therefore expressed NbCYP2 also in
insect cells. Contrary to previous studies on the precursors of
papain [36] and human cathepsin F [37], NbCYP2 was not secreted
into the culture medium. Interestingly, the intracellularly accu-
mulating proenzyme (40 kDa) was sensitive to both peptide N-
glycosidase F (PNGase F) and endoglucosaminidase H (Endo H),
indicating that its single N-glycosylation site was decorated with
oligomannosidic N-glycans. In insect cells, the exclusive presence of
such glycans is a hallmark of glycoproteins residing in the endo-
plasmic reticulum [20]. Hence, our results suggest that NbCYP2was
retained in this subcellular compartment due to improper folding
(Fig. 1b).3.2. Heterologous expression of NbCathB in insect cells
NbCathB (UniProt: Q1HER6) is predicted to be synthesized as a
39.4-kDa preproenzyme of 356 amino acids, consisting of a 26-
residue signal peptide, a latency-mediating proregion (73 amino
acids) and the C-terminal catalytic domain (257 amino acids). The
three active-site residues typical for PLCPs are all present (Cys128,
His283 and Asn304; Supplementary Table S1). NbCathB contains
three potential N-glycosylation sites, one (Asn66) present in the
propeptide and the other two (Asn112, Asn148) located in the cata-
lytic domain [17]. The theoretical molecular mass of pro-NbCathB is
36.7 kDa, whereas that of the mature protease is 28.6 kDa (not
accounting for the presence of N-linked oligosaccharides). Upon
expression of pro-NbCathB in insect cells, a 45-kDa polypeptide
could be detected. This protein was efﬁciently secreted and could
be isolated in good yields and purity, resulting in 1.8 mg electro-
phoretically homogeneous proenzyme obtained from 400 ml cul-
ture supernatant. As previously observed for human cathepsin B
[27], incubation of recombinant pro-NbCathB at low pH in the
presence of dextran sulphate resulted in the appearance of faster
migrating bands of 39 and 33 kDa. While the 39-kDa polypeptide
represents the untagged NbCathB precursor, the 33-kDa species is a
mature form of the protease (Fig. 2a). The additionally detected 23-
kDa and 14-kDa fragments were not labelled by the activity-based
probe DCG-04 (Fig. 2b) and thus represent catalytically inactive
Fig. 2. Characterization of NbCathB. (a) Recombinant NbCathB was incubated in 0.1 M
sodium acetate (pH 5.0), 2 mM cysteine in the absence or presence of 10 mg/ml dextran
sulphate (DS) prior to analysis by SDS-PAGE and silver staining. Untreated proenzyme
served as control. (b) Autoactivated NbCathB was labelled with 100 mM DCG-04 and
then subjected to enzymatic deglycosylation with PNGase F prior to western blotting
and detection of biotinylated proteins with streptavidin-peroxidase. The migration
positions of prestained molecular mass standards are indicated.
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destabilization of the enzyme by dextran sulphate. The latter bands
were not observed when pepsin was used to generate mature 33-
kDa NbCathB (data not shown). PNGase F treatment converted
the 39-kDa and 33-kDa NbCathB forms into 35-kDa and 29-kDa
polypeptides, indicating that both the precursor and the mature
enzyme are N-glycosylated (Fig. 2b). Reﬂecting the cleavage-site
preferences of pepsin, the N-terminal sequence of NbCathB pro-
cessed with this protease was determined as Leu98-Glu-Leu-Pro-
Gln, the processing site thus being in close proximity to the pre-
dicted N-terminus of the protease (Leu100; Supplementary
Table S1). Hence, the calculated molecular mass of this poly-
peptide (28.8 kDa) is in good agreement with its experimentally
determined size after enzymatic deglycosylation. In the case of self-
activated NbCathB, three overlapping N-terminal sequences were
detected in roughly equimolar amounts: Ile89-Pro-Ile-Leu-Thr,
His94-Pro-Lys-Leu-Leu, and Leu97-Leu-Glu-Leu-Pro. This was
accompanied by minor amounts of Leu92-Thr-His-Pro-Lys
(Supplementary Table S1). Based on the crystal structure of rat
procathepsin B [38], the region between Asp85 and Glu99 of
NbCathB is expected to be solvent-exposed and unstructured.
Hence, the observed processing sites are probably dictated by the
substrate speciﬁcity of NbCathB.
3.3. Heterologous expression of NbALP in insect cells
The domain organization of NbALP (UniProt: Q2QFR3) parallels
that of NbCathB. The 39.2-kDa preproenzyme of 360 amino acids is
assembled of a 22-residue signal sequence followed by the pro-
region (120 amino acids) and the protease domain (218 amino
acids) featuring the catalytic triad (Cys167, His307 and Asn327;
Supplementary Table S1). NbALP contains two potential N-glyco-
sylation sites, one (Asn127) in the propeptide and the other (Asn256)
in the catalytic domain [16]. The theoretical molecular mass of pro-
NbALP amounts to 37.0 kDa, whereas that of the fully processed
protease is 23.3 kDa (excluding any attached N-glycans). NbALP
could be produced in the baculovirus expression system with
reasonable yields (1.6 mg electrophoretically pure protein isolated
from 1000 ml culture supernatant), thus enabling its further char-
acterization. Recombinant pro-NbALP migrated on SDS-PAGE gelsas a 38-kDa polypeptide. In contrast to NbCathB, incubation at low
pH did not result in substantial NbALP autoprocessing, even in the
presence of dextran sulphate. These ﬁndings suggest that pro-
NbALP is not capable of efﬁcient autoactivation (Fig. 3a). Enzy-
matic deglycosylation with PNGase F shifted the estimated mo-
lecular mass of recombinant pro-NbALP to 36 kDa (Fig. 3b).
It has been observed previously that efﬁcient proteolytic
maturation of barley aleurain requires the presence of other PLCPs
[39]. Indeed, incubation of recombinant pro-NbALP with catalytic
amounts of human cathepsin L or a cathepsin L-like PLCP from
N. benthamiana (NbC14) resulted in almost quantitative conversion
of the precursor into a 25-kDa polypeptide reminiscent of the
mature form of the protease. By contrast, treatment of pro-NbALP
with NbCathB did not result in detectable processing (Fig. 3c).
The N-terminus of mature NbALP generated by treatment with
human cathepsin L was determined as Asn140-Val-Val-Leu-Pro,
positioned three residues upstream of the ﬁrst amino acid of the
catalytic domain (Leu143; Supplementary Table S1). Interestingly,
N-terminal extensions of 2e4 residues were also reported for
barley aleurain and its mammalian homologue cathepsin H [40,41].
3.4. Catalytic features of recombinant N. benthamiana PLCPs
The enzymatic characterization of NbCathB and NbALP has so
far been restricted to the detection of endogenous forms of these
proteases in N. benthamiana extracts using the activity-based probe
DCG-04 [17,19]. We have therefore tested both recombinant en-
zymes for their reactivity with DCG-04 and two other irreversible
PLCP inhibitors, biotin-CA074 [33] and biotin-Leu-Val-Gly-CHN2
[32]. In the case of NbCathB, biotin-CA074 was superior to DCG-04
in labelling the active form of the protease. This preference is
probably accounted for by the fact that biotin-CA074 is a derivative
of the cathepsin B-selective inhibitor CA-074. However, it should be
noted that plant cathepsin B is less susceptible to CA-074 inhibition
than its human counterpart [42]. Biotin-Leu-Val-Gly-CHN2 has also
been already sucessfully used to detect active species of cathepsin B
[43]. However, this compound labels the human enzyme substan-
tially weaker than DCG-04 or biotin-CA074 (data not shown).
Interestingly, labelling of NbCathB by biotin-Leu-Val-Gly-CHN2 was
also faint (Fig. 4). Incubation of NbALP with DCG-04 yielded two
labelled bands of 25 and 35 kDa corresponding to the mature form
of the protease and a processing intermediate, respectively. The
same was observed upon treatment of NbALP with biotin-CA074.
Similar to NbCathB, labelling of NbALP by biotin-Leu-Val-Gly-
CHN2 was not pronounced (Fig. 4).
We have also assessed the catalytic properties of mature NbALP
and NbCathB using synthetic substrates frequently used to monitor
the activities of PLCPs. Enzymatic characterization of NbALP was
performed at pH 6.8 to permit comparison with the known kinetic
features of barley aleurain. Like the latter enzyme, NbALP readily
cleaves Arg-MCA which demonstrates its capacity to act as an
aminopeptidase (Table 1). The kcat values of NbALP and aleurain for
this substrate comparewell considering the slightly more acidic pH
optimum of NbALP (pH 6.0; data not shown) and the lower assay
temperature used in the current study. The Km values are also in the
same range [40,44]. NbCathB is very effective in cleaving Z-Phe-
Arg-MCA and Z-Arg-Arg-MCA (Table 1). Interestingly, NbCathB
hydrolyses these two endopeptidase substrates with similar cata-
lytic efﬁciencies even at the optimal pH for cleavage of the former
compound (pH 4.5). Since human cathepsin B also displays sub-
stantial peptidyldipeptidase activity (removing C-terminal di-
peptides) at this pH, we have tested NbCathB for its capacity to act
on two synthetic peptidyldipeptidase substrates. Although Abz-
Phe-Arg-Phe(NO2)-Ala [29] proved to be a similarly good substrate
for NbCathB and human cathepsin B, the Km and kcat values of the
Fig. 3. Characterization of NbALP. (a) Recombinant NbALP was incubated in 0.1 M sodium acetate (pH 5.0), 2 mM cysteine in the absence or presence of 10 mg/ml dextran sulphate
(DS) prior to analysis by SDS-PAGE and silver staining. Untreated proenzyme served as control. (b) NbALP was subjected to enzymatic deglycosylation with PNGase F prior to
immunoblotting analysis with anti-aleurain antibodies. (c) NbALP (200 ng) was treated for 30 min with NbC14 (5 ng), NbCathB (200 ng), human cathepsin L (20 ng) or with no
enzyme added and then analysed by immunoblotting as above. Untreated NbALP served as control. The migration positions of prestained molecular mass standards are indicated.
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human protease. Furthermore, NbCathB cleaves another pepti-
dyldipeptidase substrate, Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH
[30] far less efﬁciently than human cathepsin B (Table 1). Taken
together, these data suggest that NbCathB acts primarily as an
endopeptidase.
We have also tested NbALP and NbCathB for their capacity to
degrade monoclonal antibodies, which are currently the heterolo-
gous proteinsmost frequently produced inN. benthamiana [1,4]. For
these experiments, the two human anti-HIV-1 IgG1k antibodies
2F5 and 2G12 were chosen as substrates. It has been reported
previously that 2F5 is far more sensitive to proteolysis than 2G12.
Digestion of either mAb with human cathepsin L yielded two
characteristic heavy-chain degradation products of 30 and 40 kDa,
whereas human cathepsin B could only generate the 40-kDa 2F5
fragment [10]. Likewise, treatment of 2F5 with NbCathBFig. 4. Proﬁling of N. benthamiana PLCPs with activity-based probes. Activated NbALP
and NbCathB were incubated with the indicated concentrations of DCG-04, biotin-Leu-
Val-Gly-CHN2 (LVG) or biotin-CA074 (CA074) for 30 min at 37 C followed by SDS-PAGE
and western blotting using streptavidin-peroxidase for detection. The migration po-
sitions of prestained molecular mass standards are indicated. *, NbALP processing
intermediate.preferentially resulted in the formation of a 40-kDa polypeptide,
although minor amounts of smaller bands were also detected upon
prolonged incubation. Essentially the same 2F5 cleavage pattern
was observed for NbALP, but the extent of mAb processing was far
less pronounced than for NbCathB (Fig. 5). For both NbALP and
NbCathB, cleavage of the 2F5 heavy chain occurred largely within
the H3 loop of the complementarity-determining region (CDR) af-
ter Gly108 (LFG108YV109PIAR; Supplementary Table S2) as previ-
ously reported for human cathepsin B [10] and tobacco cell cultures
[11]. In contrast to its human counterpart, NbCathB was capable of
hydrolysing also the othermAb, 2G12, giving rise to 30-kDa and 40-
kDa heavy-chain fragments. However, 2G12 proved refractory to
proteolysis by NbALP.
4. Discussion
Based on a comprehensive phylogenetic analysis, plant PLCPs
have been divided into 9 subfamilies [14]. The ﬁrst six subfamilies
all comprise cathepsin L-like proteases which differ in individual
molecular aspects. Subfamilies 7e9 are phylogenetically distinct
and display homologies to cathepsins F, H and B, respectively. The
three N. benthamiana PLCPs characterized in this study belong to
subfamilies 7 (NbCYP2), 8 (NbALP) and 9 (NbCathB). In a previous
study, synthetic inhibitor libraries have been used to probe the
catalytic features of proteases representing these subfamilies.
Notably, the limited enzymatic characterization of NbCYP2 ach-
ieved in the current study is consistent with the substrate speci-
ﬁcity of Arabidopsis thaliana RD19, the prototype of subfamily 7
[14].Table 1
Kinetic parameters of recombinant N. benthamiana PLCPs.
PLCP Substrate Km [mM] kcat [s1] kcat/Km [mM1 s1]
NbALP Arg-MCA 99 ± 8 1.5 ± 0.2 15
NbCathB Z-Arg-Arg-MCA 99 ± 7 11 ± 1 111
Z-Phe-Arg-MCA 48 ± 4 4.7 ± 2.3 98
Abz-FRF(NO2)Ab 1.4 ± 0.2 2.9 ± 0.1 2037
Abz-GIVRAK(Dnp)c 0.8 ± 0.3 0.10 ± 0.01 116
huCathBa Abz-FRF(NO2)Ab 17 ± 2 24 ± 1 1434
Abz-GIVRAK(Dnp)c 3.9 ± 0.7 25 ± 1 6487
a huCathB, human cathepsin B.
b Abz-FRF(NO2)A, Abz-Phe-Arg-Phe(NO2)-Ala.
c Abz-GIVRAK(Dnp), Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH.
Fig. 5. Processing of anti-HIV-1 mAbs by N. benthamiana PLCPs. mAb 2F5 or 2G12 (200 ng) was incubated with NbALP (50 ng), NbCathB (50 ng) or with no enzyme added (control)
for the indicated times and then analysed by immunoblotting with antibodies to the heavy chain of human IgG. The migration positions of selected molecular mass standards are
indicated. o/n, overnight (16 h).
M. Niemer et al. / Biochimie 122 (2016) 119e125124Human cathepsin B has the capacity to function as an endo-
peptidase as well as a peptidyldipeptidase, the latter activity being
facilitated by two histidine residues present in a unique insertion
commonly referred to as the occluding loop [29]. In plant cathepsin
B-like proteases, this additional segment is considerably shorter
and lacks one of the critical histidine residues [42]. However, the
peptidyldipeptidase activity of plant cathepsin B has not been
systematically tested before. Using a suitable internally quenched
ﬂuorescence substrate (Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH;
[30]), we have now obtained evidence that NbCathB could have a
substantially lower peptidyldipeptidase activity than human
cathepsin B. This would be in good agreement with the very slow
inactivation of daikon cathepsin B by CA-074, a mechanism-based
inhibitor exploiting the peptidyldipeptidase activity of the human
enzyme [42]. Interestingly, a different peptidyldipeptidase sub-
strate (Abz-Phe-Arg-Phe(NO2)-Ala; [29]) was cleaved by NbCathB
and human cathepsin B with comparable catalytic efﬁciencies. In
contrast to Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH, Abz-Phe-Arg-
Phe(NO2)-Ala is also a good substrate for PLCPs which are obligate
endopeptidases [45]. Reminiscent of the latter enzymes [30],
NbCathB hydrolysed both internally quenched ﬂuorescence sub-
strates with a much lower Km than human cathepsin B. In this
context, it is also of note that NbCathB was more effective in mAb
degradation than the human enzyme [10]. Taken together, these
data support the notion that plant cathepsin B-like proteases
possess higher endopeptidase activity than their animal counter-
parts due to the presence of a shorter occluding loop [42].
As for mammalian cathepsin H, the aminopeptidase activity of
aleurain-like proteases is based on the presence of the propeptide-
derived minichain which remains attached to the mature enzyme
through a disulphide bridge not present in other PLCPs [40]. This
octapeptide occupies parts of the substrate-binding cleft and
thereby compromises the endopeptidase activity of the enzyme,
which possibly explains why cathepsin H and its plant orthologuescannot undergo autocatalytic processing [46]. For barley aleurain,
evidence has been provided that precursor maturation involves the
action of RD21-like proteases [39]. However, we have recently
shown that aleurain-like protease processing is normal in an
A. thaliana mutant deﬁcient in RD21 [19]. These results are
consistent with our ﬁndings that various other cathepsin L-like
PLCPs are capable of converting pro-NbALP into the mature form of
the protease. The Km and kcat values of NbALP for the aminopepti-
dase substrate Arg-MCA are similar to those reported for barley
aleurain and rat cathepsin H [44,47], thus conﬁrming proper pro-
cessing of the enzyme. Despite steric hindrance by the minichain,
cathepsin H and its relatives still have the capacity to act as en-
dopeptidases [48]. This is in line with our observation that NbALP is
capable of cleaving the anti-HIV-1 mAb 2F5 at the same site of its
CDR H3 loop as NbCathB. However, the activity of NbALP towards
mAb substrates was far lower than observed for NbCathB. This
suggests that the latter enzyme is better suited as target for down-
regulation of unintended mAb proteolysis in N. benthamiana.
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